NFKB1 and cancer: Inhibits NF-κB activity in vitro and shows antiproliferative activity against various human cancer cell lines, namely ACHN (renal), NCI-H23(lung), MDA-MB-231 (breast), HCT-15 (colon), NUGC-3 (stomach) and PC-3 (prostate).